Industry News
Pharmaceutical Industry News
BioNTech advocate accused of undermining WHO’s African mRNA production campaign: report
BioNTech advocate accused of undermining WHO's African mRNA production campaign: report fkansteiner Wed, 02/09/2022 - 14:08
GlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark
GlaxoSmithKline's COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark aliu Wed, 02/09/2022 - 11:25
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll fkansteiner Wed, 02/09/2022 - 09:55
Roche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ plans as Eylea battle looms
Roche pharma CEO Anderson talks up Vabysmo’s 'very strong launch' plans as Eylea battle looms badams Wed, 02/09/2022 - 09:54
Karyopharm ready to take new Xpovio indication to the FDA but analysts hold out for details
Karyopharm ready to take new Xpovio indication to the FDA but analysts hold out for details esagonowsky Wed, 02/09/2022 - 08:46
Amgen talks long-term growth, but doubts remain for analysts, investors
Amgen talks long-term growth, but doubts remain for analysts, investors kdunleavy Tue, 02/08/2022 - 14:41
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT
J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT fkansteiner Tue, 02/08/2022 - 13:51
Eli Lilly, Innovent’s PD-1 in troubled waters as FDA review, oncology chief’s comments portend likely rejection
Eli Lilly, Innovent’s PD-1 in troubled waters as FDA review, oncology chief's comments portend likely rejection aliu Tue, 02/08/2022 - 13:06
As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus going away for ‘foreseeable future’
As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn't see virus going away for 'foreseeable future' fkansteiner Tue, 02/08/2022 - 11:28
J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
Incyte’s eczema cream Opzelura off to ‘very successful’ launch despite FDA warning: CEO
Incyte’s eczema cream Opzelura off to ‘very successful’ launch despite FDA warning: CEO aliu Tue, 02/08/2022 - 10:52
Getting more Black women into cancer trials ‘not a marketing campaign, it’s a movement’
Getting more Black women into cancer trials ‘not a marketing campaign, it’s a movement’ sharon.coey Tue, 02/08/2022 - 10:38
Merck KGaA forms new life sciences unit in push to strengthen its CDMO position
Merck KGaA forms new life sciences unit in push to strengthen its CDMO position jkeenan Tue, 02/08/2022 - 10:02
Azurity bags FDA nod for grape-flavored multiple sclerosis drug
Azurity bags FDA nod for grape-flavored multiple sclerosis drug ntaylor Tue, 02/08/2022 - 09:24
CDMO Piramal earmarks $74M for upgrades to UK antibody, API manufacturing sites
CDMO Piramal earmarks $74M for upgrades to UK antibody, API manufacturing sites jkeenan Tue, 02/08/2022 - 08:51
Novo Nordisk’s Wegovy passes NICE checkpoint on course to blockbusterland
Novo Nordisk's Wegovy passes NICE checkpoint on course to blockbusterland fkansteiner Tue, 02/08/2022 - 08:36
Amgen’s COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4
Amgen's COVID-19 manufacturing deal with Lilly helped compensate for lagging Aimovig, Enbrel in Q4 kdunleavy Mon, 02/07/2022 - 17:42
FDA must shore up plans for surprise foreign inspections, rev up hiring of overseas investigators, GAO says
FDA must shore up plans for surprise foreign inspections, rev up hiring of overseas investigators, GAO says fkansteiner Mon, 02/07/2022 - 14:51
Teva forks over $150M to settle Texas opioid suit
Teva forks over $150M to settle Texas opioid suit fkansteiner Mon, 02/07/2022 - 11:33
UPDATED: Teva forks over $225M to settle Texas opioid suit
UPDATED: Teva forks over $225M to settle Texas opioid suit fkansteiner Mon, 02/07/2022 - 11:33